Video
Dr Madhav Thambisetty
Video
02/04/2024
In this video, Madhav Thambisetty, MD, discusses a new treatment for patients with Alzheimer disease, lecanemab, recently approved by the FDA, including the presumed mechanism of action, benefits, risks,...
02/04/2024
Video
Video
02/03/2024
In this video, Jesse L. Berry, MD, discusses her team's study that examined the use of aqueous humor liquid biopsy to determine metastatic risk in patients with uveal melanoma (UM). Dr Berry talks about how...
02/03/2024
Video
Video
02/03/2024
In this video, Jesse L. Berry, MD, discusses her team's study that examined the use of aqueous humor liquid biopsy to determine metastatic risk in patients with uveal melanoma (UM). Dr Berry talks about how...
02/03/2024
Video
Video
02/03/2024
In this video, Jesse L. Berry, MD, discusses her team's study that examined the use of aqueous humor liquid biopsy to determine metastatic risk in patients with uveal melanoma (UM). Dr Berry talks about how...
02/03/2024
Video
Video
02/03/2024
In this video, Jesse L. Berry, MD, discusses her team's study that examined the use of aqueous humor liquid biopsy to determine metastatic risk in patients with uveal melanoma (UM). Dr Berry talks about how...
02/03/2024
Video
Video
02/03/2024
In this video, Jesse L. Berry, MD, discusses her team's study that examined the use of aqueous humor liquid biopsy to determine metastatic risk in patients with uveal melanoma (UM). Dr Berry talks about how...
02/03/2024
Video
Video
02/03/2024
In this video, Jesse L. Berry, MD, discusses her team's study that examined the use of aqueous humor liquid biopsy to determine metastatic risk in patients with uveal melanoma (UM). Dr Berry talks about how...
02/03/2024
Video
Video
01/27/2024
In this video, Jonathan Silverberg, MD, PhD, MPH, discusses his team's study, which found that lebrikizumab was highly effective in treating symptoms of moderate-to-severe atopic dermatitis in adults and...
01/27/2024
Video
Video
01/27/2024
In this video, Jonathan Silverberg, MD, PhD, MPH, discusses his team's study, which found that lebrikizumab was highly effective in treating symptoms of moderate-to-severe atopic dermatitis in adults and...
01/27/2024
Video
Video
01/27/2024
In this video, Jonathan Silverberg, MD, PhD, MPH, discusses his team's study, which found that lebrikizumab was highly effective in treating symptoms of moderate-to-severe atopic dermatitis in adults and...
01/27/2024